Iovance Biotherapeutics Inc at Barclays Global Healthcare Conference Transcript
So first and foremost for us at Barclays down in Miami, this is our last session for the conference. So thank you for everyone for attending and making this live event happen and for everyone who's been enthusiastic or the questions or the participation or your time, so much appreciated. It's the first event in a couple of years, and it feels like we're getting back to normal, which is fantastic.
So good to be in person.
Yes. Yes, exactly. So my name is Peter Lawson, and I'm the biotech analyst, or one of the biotech analysts at Barclays. I cover -- have the pleasure of covering our events. So up on the stage, I've got Jean-Marc Bellemin, CFO; and Madan Jagasia, SVP of Medical Affairs. We had dinner last night and that went very well, and I'm sure there's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |